Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

NCT06124976 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma of the Renal Pelvis and Ureter
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

DRUG: ST-02

Sponsor

University of British Columbia